By Michael Balsamo and Ann D'Innocenzio

The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.

The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.

The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.

Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.

“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”

The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.

AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.

The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.

In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.

Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.

The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.

Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.

Updated on December 22, 2020, at 3:44 p.m. ET with additional details.

Share:
More In Business
China Urges Families to Stock Up Ahead of Winter Amid Supply Crunch
The Chinese government causing quite a stir after urging families to stock up on essentials ahead of winter months amid a global energy crisis and supply chain woes disruptions. Keith Krach, the former Under Secretary of State and former DocuSign Chairman and CEO, joined Cheddar News to discuss.
Hospitality Industry Reports Earnings as Travel Slowly Returns
It's earnings season for the hospitality industry, with Marriott, MGM, Booking Holdings, and Hyatt all set to report on November 3. The stakes are high as investors look for signs that travel is returning after months of pandemic-related disruptions. Hilary Kramer, chief investment officer for Kramer Capital Research, joined Cheddar to explain why the industry still has a long way to go when it comes to recovering from the pandemic.
Stocks Hit Record Highs on Fed Announcement About Tapering, Interest Rates
The Federal Reserve announced it would begin tapering asset purchases in mid-November and that it would keep interest rates low. Stocks hit a record high on the announcement. Dan Eye, Head of Asset Allocation & Equity Research at Fort Pitt Capital Group, joins Cheddar News' Closing Bell to discuss the Fed news, as well as Q3 earnings season.
Stocks Close Mixed, S&P 500 and Nasdaq Hit Record Highs
Both the S&P 500 and Nasdaq hit new highs Thursday, with investors keeping an eye on strong economic data, and tech stocks boosting the Nasdaq. The Dow closed lower, but hovered near a record. Brandon Pizzurro, Director of Public Investments at GuideStone Capital Management, joins Cheddar News' Closing Bell to discuss today's close, Q3 earnings season so far, and 2022 outlook amid Fed announcements.
CarDekho Raises $250 Million in Pre-IPO Round
The largest car search platform in India, Cardekho, recently raised $250 million in what the company calls a pre-IPO round led by leapfrog investments. The funding bumps CarDekho above unicorn status with a $1.2 billion valuation. The company currently has a catalogue of more than 3,000 pre-owned cars for online purchases and hopes to expand with the new funding. Partner and co-head of South Asian investment for LeapFrog Stewart Langdon joins Cheddar News' Closing Bell to discuss.
Load More